Articles
| Open Access |
https://doi.org/10.37547/ajbspi/Volume03Issue05-04
AWARENESS AMONG PEOPLE BASED ON NEURO ONCOLOGY
Abstract
Limitations in trial design, accrual, and data reporting impact efficient and reliable drug evaluation in cancer clinical trials. These concerns have been recognized in neuro-oncology but have not been comprehensively evaluated. We conducted a semi- automated survey of adult interventional neuro-oncology trials, examining design, interventions, outcomes, and data availability trends. Trials were selected programmatically from ClinicalTrials.gov using primary malignant CNS tumour classification terms. Regression analyses assessed design and accrual trends; effect size analysis utilized survival rates among trials investigating survival.
Keywords
Primary Central Nervous System malignancies, clinical trial design trends, trial accrual
References
Haddad P, Shazadi S, Samiei F, Kharrazi HH, Tabatabaeefar M, Rakhsha A, Faranoosh M, Torabi-Nami M, Dadras A, Liaghi A, Nafarieh L. An overview of neuro-oncology research and practice in Iran, three years with the NOSC initiative. Int J Clin Exp Med. 2015 Mar 15;8(3):3946-55. PMID: 26064296; PMCID: PMC4443130.
Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, Brown PD, Camidge DR, Chiang VL, Davies MA, Hu LS, Huang RY, Kaufmann T, Kumthekar P, Lam K, Lee EQ, Lin NU, Mehta M, Parsons M, Reardon DA, Sheehan J, Soffietti R, Tawbi H, Weller M, Wen PY. Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro Oncol. 2022 Oct 3;24(10):1613-1646. doi: 10.1093/neuonc/noac118. PMID: 35762249; PMCID: PMC9527527.
Armstrong TS. Survivorship in Neuro-Oncology. Neuro Oncol. 2018 Nov 9;20(suppl_7):vii4-vii5. doi: 10.1093/neuonc/noy173. PMID: 30412259; PMCID: PMC6225750.
Мирхамидова С. М., Динмухаммадиев Н. А. Особенности распространенности онкологических заболеваний //Молодой ученый. – 2016. – №. 20. – С. 84-87.
Levin VA. Drug discovery in neuro-oncology: challenges in the path forward. Neuro Oncol. 2018 Mar 27;20(4):435-436. doi: 10.1093/neuonc/noy004. PMID: 29538691; PMCID: PMC5909643.
Millward CP, Armstrong TS, Barrington H, Brodbelt AR, Bulbeck H, Byrne A, Dirven L, Gamble C, Grundy PL, Islim AI, Javadpour M, Keshwara SM, Krishna ST, Mallucci CL, Marson AG, McDermott MW, Meling TR, Oliver K, Pizer B, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD. Opportunities and challenges for the development of "core outcome sets" in neuro-oncology. Neuro Oncol. 2022 Jul 1;24(7):1048-1055. doi: 10.1093/neuonc/noac062. PMID: 35287168; PMCID: PMC9248398.
Lin E, Rosenthal MA, Le BH, Eastman P. Neuro-oncology and palliative care: a challenging interface. Neuro Oncol. 2012 Sep;14 Suppl 4:iv3-7. doi: 10.1093/neuonc/nos209. PMID: 23095828; PMCID: PMC3480249.